I now have comprehensive information to deliver a detailed answer. Let me compile everything.
Ectopic Pregnancy
An ectopic pregnancy is implantation of the fertilized ovum outside the uterine cavity. It accounts for approximately 1-2% of all pregnancies and is the 3rd leading cause of maternal death (responsible for ~2.7-10% of maternal deaths).
Sites of Implantation
| Site | Frequency | Notes |
|---|
| Fallopian tube (overall) | ~95-98% | Most common site |
| - Ampulla | ~70% | Most common tubal site |
| - Isthmus | ~12% | Ruptures earlier, more dangerous |
| - Fimbriae | ~11% | |
| - Interstitial (cornual) | ~2-3% | Highest mortality; ruptures late at 8-16 wks with massive hemorrhage |
| Ovarian | ~0.5-1% | |
| Cervical | <1% | |
| Abdominal | ~1% | Can progress to advanced gestational age; very rare |
| Heterotopic | ~1:4,000 | Simultaneous intra + extrauterine; higher with ART |
Risk Factors
Most important risk factor = Prior ectopic pregnancy (recurrence risk 10-15% after first, 30% after second)
| Risk Factor | Notes |
|---|
| Prior ectopic pregnancy | Strongest single risk factor |
| Pelvic inflammatory disease (PID) | Tubal damage in ~90% of ectopics; Chlamydia cultured in 7-30% |
| Tubal surgery / sterilization | Sterilization failure → 10-year ectopic rate ~7.3/1,000 |
| Assisted reproductive technology (IVF) | Multiple embryo transfer increases heterotopic risk |
| History of infertility | Increases risk 4-40x depending on cause |
| IUD in situ | If pregnancy occurs despite IUD, more likely ectopic |
| Smoking | Dose-dependent; alters tubal motility and ciliary activity |
| Endometriosis | Tubal/peritoneal scarring |
| Salpingitis isthmica nodosa | |
| Prior abdominal/pelvic surgery | |
Up to 50% of women with ectopic pregnancy have no identifiable risk factor - so a high index of suspicion is always required.
Pathophysiology
- Fertilized ovum normally reaches the uterus in ~3-4 days via ciliary action + peristalsis
- Any factor delaying transit through the tube leads to implantation before reaching the uterus
- The fallopian tube cannot support placentation - trophoblastic invasion leads to erosion of tubal wall → rupture and hemorrhage
- Isthmic ectopics rupture earlier (thinner wall, smaller lumen) than ampullary ones
Clinical Features
Classic Triad (present in ~50% of cases)
- Abdominal/pelvic pain (most common - may be unilateral, dull/sharp/crampy)
- Amenorrhea (missed period ~6-8 weeks)
- Vaginal bleeding (usually light, dark spotting)
Additional Symptoms
- Shoulder tip pain - referred pain from diaphragmatic irritation by hemoperitoneum (indicates rupture)
- Syncope / dizziness with rupture
- Transient pain relief can occur with rupture (stretching of tubal serosa ceases)
Physical Examination
| Finding | Notes |
|---|
| Adnexal tenderness | Most consistent sign |
| Adnexal mass | Palpable in ~50% (may be corpus luteum, not ectopic itself) |
| Cervical motion tenderness | Variable |
| Ruptured: tachycardia, hypotension, rigid abdomen, rebound | Hemodynamic instability = emergency |
Diagnosis
1. Beta-hCG (Serum Quantitative)
- Positive in virtually all ectopic pregnancies
- In normal IUP: doubles every 48 hours (minimum 53-66% rise)
- In ectopic: slower rise, plateau, or abnormal decline
- Discriminatory zone: β-hCG level at which an IUP should be visible on TVUS
- Transvaginal: 1,500-2,000 mIU/mL (some institutions use 3,510 mIU/mL to avoid false positives)
- No IUP seen above discriminatory zone → strongly suspect ectopic
- Note: ectopic hCG does NOT correlate with ectopic size
2. Serum Progesterone
- >25 ng/mL: strongly suggests viable IUP (only 1-2% of ectopics this high)
- <5 ng/mL: suggests non-viable pregnancy (IUP or ectopic)
3. Transvaginal Ultrasound (TVUS)
- Imaging modality of choice
- Key findings:
- Empty uterine cavity
- Pseudogestational sac (intrauterine fluid collection): occurs in 8-29% of ectopics; mimics IUP
- Double decidual sac sign (DDSS): two echogenic rings = true IUP
- Adnexal ring sign: echogenic ring around extrauterine sac (seen in <50% of ectopics)
- Complex/solid adnexal mass
- Free fluid in the cul-de-sac (not proof of rupture)
- Intra-abdominal free fluid above the uterus → suggests rupture
4. Dilation and Curettage (D&C)
- Performed when pregnancy confirmed non-viable and location unknown
- Presence of chorionic villi (float in saline, lacy frond appearance) = IUP
- Absence of villi with declining hCG post-curettage = ectopic
Treatment
Treatment depends on: hemodynamic stability, ectopic site, size, hCG level, patient's fertility goals, and resources.
A. Expectant Management
- Reserved for selected stable patients with: declining hCG, small ectopic, no cardiac activity, reliable follow-up
- Close serial hCG monitoring required
B. Medical Treatment: Methotrexate (MTX)
MTX is a folic acid antagonist that inhibits trophoblastic cell division.
Eligibility criteria (all must be met):
- Hemodynamically stable
- Unruptured ectopic
- No contraindications to MTX
- Reliable for follow-up
- hCG typically <5,000 mIU/mL (higher levels = higher failure rate)
- Ectopic mass <4 cm (with no cardiac activity)
Absolute contraindications:
- Hemodynamic instability / rupture
- Breastfeeding
- Immunodeficiency
- Renal/hepatic/hematologic dysfunction
- Active pulmonary disease
- Peptic ulcer disease
- Sensitivity to MTX
- Intrauterine pregnancy
Regimens:
| Regimen | Dose | Monitoring | Success Rate |
|---|
| Single dose | 50 mg/m² IM on day 1 | β-hCG days 4 & 7; if <15% drop → 2nd dose | ~78-96% overall; 15-20% need 2nd dose |
| Two-dose | MTX day 0 and day 4 | β-hCG days 4 & 7 | ~87% |
| Multidose | 1 mg/kg IM days 1,3,5,7 + leucovorin alternate days | β-hCG each treatment day | Higher efficacy, more side effects |
Side effects (dose-dependent): nausea, vomiting, stomatitis, abdominal pain (30-40%); bone marrow suppression, hepatotoxicity, alopecia, pneumonitis (less common)
Post-MTX precautions: Avoid alcohol, NSAIDs, folate supplements, sexual intercourse, sun exposure; avoid new pregnancy for 3 months
C. Surgical Treatment
- Indicated for: rupture, hemodynamic instability, MTX failure/contraindication, or patient preference
| Approach | Preferred over | Notes |
|---|
| Laparoscopy | Laparotomy in most cases | Shorter hospital stay, less blood loss, faster recovery, fewer adhesions |
| Laparotomy | When hemodynamically unstable, extensive adhesions, or abdominal pregnancy | Faster entry if hemorrhage is massive |
Procedures:
| Procedure | When Used | Notes |
|---|
| Salpingectomy | Ruptured tube, patient not concerned with ipsilateral fertility, severely damaged tube | Recurrent ectopic rate lower (4% vs 10% with salpingostomy) |
| Salpingostomy (linear) | Unruptured ectopic, patient wants to preserve fertility, contralateral tube absent/damaged | Risk of persistent ectopic ~8%; post-op weekly hCG monitoring required |
| Milking | Only if fimbrial location | Associated with higher recurrence; generally not recommended for ampullary ectopics |
Reproductive Outcomes After Treatment
| Treatment | Subsequent IUP Rate | Recurrent Ectopic Rate | Tubal Patency |
|---|
| Laparoscopic salpingostomy | ~60% | ~10% | ~84% ipsilateral |
| Laparoscopic salpingectomy | ~54% | ~4% | N/A |
| Methotrexate | 36-64% | ~10% | >80% |
- No significant difference in future fertility between MTX and salpingostomy overall
Special Types
Interstitial (Cornual) Ectopic
- Located in myometrial portion of tube
- Larger blood supply → late rupture at 8-16 weeks, massive hemorrhage
- Treatment: MTX preferred if unruptured; surgical = cornual resection
Cervical Ectopic
- Implants in cervical canal
- Conservative options: MTX, uterine artery ligation + hysteroscopic resection
- Hysterectomy sometimes required
Ovarian Ectopic
- Criteria (Spiegelberg): tube intact on same side, mass in ovarian position, ovarian tissue in wall, connected to uterus by utero-ovarian ligament
- Treatment: cystectomy/wedge resection; MTX has been used successfully
Abdominal Ectopic
- Most dangerous; can reach advanced gestation
- Treatment: surgical - laparotomy (placenta removal risks massive hemorrhage; often left in situ)
Sources: Berek & Novak's Gynecology; Rosen's Emergency Medicine; Schwartz's Principles of Surgery; Creasy & Resnik's Maternal-Fetal Medicine